SCHEMBL8682160

SCHEMBL8682160

CCOC(=O)c1ccc2c(cnn2[C@H](C)CC#N)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 3/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
EZH2 Q15910 1/20 0.39
HSD17B2 P37059 1/20 0.39
RAB9A P51151 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
THRB P10828 1/20 0.39
NPC1 O15118 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
MAPT P10636 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4123693 0.85 EZH2 (0.51) HSD17B10ALDH1A1HPGDCA12CA1
Hydrochloric Acid SCHEMBL8683796 0.82 ALDH1A1 (0.40) ALDH1A1HPGDCA12CA1CA2
Hydrochloric Acid SCHEMBL8683788 0.82 ALDH1A1 (0.40) ALDH1A1HPGDCA12CA1CA2
SCHEMBL8687401 0.77 CYP1A2 (0.50) HSD17B10HTTALDH1A1HPGDCA12
SCHEMBL3436319 0.76 CCNC (0.49) HSD17B10ALDH1A1CA12CA1CA2
SCHEMBL904672 0.74 MAPT (0.48) ALDH1A1HPGDCA12CA1CA2
SCHEMBL8682678 0.74 ITGB3 (0.46) HTTALDH1A1EZH2RAB9AMEN1
SCHEMBL7426706 0.73 CHEK1 (0.56) ALDH1A1CA12CA1CA2CA7
SCHEMBL7425720 0.73 SIRT2 (0.39) ALDH1A1HPGDCA12CA1CA2
SCHEMBL16595907 0.73 EZH2 (0.49) HSD17B10ALDH1A1HPGDEZH2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760028-A TREATING CANCER METASTASIS, DIABETIC RETINOPATHY, NEOVASCULAR GLAUCOMA, THROMBOSIS, RESTENOSIS, OSTEOPOROSIS, MACULAR DEGENERATION THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-02 US disclosed